Megan T. Donnelly, DO
(Novant Health)
|
Dr. Donnelly has received personal compensation for serving as an employee of Novant Health. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AndHealth. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Donnelly has a non-compensated relationship as a Communications Director with Southern Headache Society that is relevant to AAN interests or activities. |
Charles S. DeCarli, MD, FAAN
(UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center)
|
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |